Illumina has named Daniel Grosu to the newly created position of vice president and chief medical officer. Grosu will "play a key role in building Illumina's diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina's CLIA-certified clinical laboratory," the firm said.
Prior to joining Illumina, Grosu was group director of clinical science and clinical and medical affairs at Ortho-Clinical Diagnostics. He was also previously the director and global clinical leader of global clinical development for Bayer Healthcare Pharmaceuticals' diagnostic imaging business. Before that, Grosu worked at Siemens Medical Solutions.
He earned a medical degree from Saint Louis University and an MBA from the University of Oxford.
Oxford Gene Technology has tapped Tim Hall to be its new finance director as of January 2012.
Hall most recently was finance director of Lombard Medical Technologies. He also was director of strategic planning at Medeva and chief financial officer at Celltech Pharmaceuticals.
Hall has a business administration degree from the University of Bath in the UK and qualified as an accountant with Touche Ross.